IRIS
RUSSOTTO, Ylenia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.293
NA - Nord America 1.205
AS - Asia 615
SA - Sud America 183
Continente sconosciuto - Info sul continente non disponibili 118
AF - Africa 22
OC - Oceania 2
Totale 3.438
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.129
RU - Federazione Russa 802
SG - Singapore 237
IT - Italia 194
CN - Cina 153
BR - Brasile 146
HK - Hong Kong 57
IE - Irlanda 57
VN - Vietnam 57
DE - Germania 45
CA - Canada 34
SE - Svezia 32
FI - Finlandia 29
GB - Regno Unito 28
IN - India 27
FR - Francia 26
NL - Olanda 17
MX - Messico 16
AT - Austria 14
AR - Argentina 11
PL - Polonia 11
TR - Turchia 11
JP - Giappone 10
ZA - Sudafrica 10
BD - Bangladesh 9
EC - Ecuador 9
ES - Italia 9
NI - Nicaragua 8
IQ - Iraq 6
PK - Pakistan 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
ID - Indonesia 5
MA - Marocco 5
MY - Malesia 5
PH - Filippine 5
BG - Bulgaria 4
VE - Venezuela 4
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
RO - Romania 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
AL - Albania 2
AU - Australia 2
BE - Belgio 2
CI - Costa d'Avorio 2
CL - Cile 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EE - Estonia 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
PE - Perù 2
UY - Uruguay 2
AO - Angola 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KY - Cayman, isole 1
LV - Lettonia 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
NP - Nepal 1
PR - Porto Rico 1
PY - Paraguay 1
SV - El Salvador 1
TH - Thailandia 1
Totale 3.321
Salva come PNG Salva come JPEG
Città #
Moscow 225
Ashburn 195
San Jose 141
Dallas 125
Singapore 123
Hong Kong 57
Council Bluffs 56
Dublin 56
The Dalles 45
Los Angeles 44
Beijing 35
New York 31
Chandler 30
Munich 29
Nyköping 21
Ho Chi Minh City 19
Rome 19
Palermo 18
Orem 17
Catania 16
Santa Clara 16
Hanoi 15
Buffalo 14
Turku 14
Boardman 12
Montreal 12
São Paulo 12
Milan 11
Atlanta 10
Denver 10
Guangzhou 10
Phoenix 10
Vienna 10
Pune 9
Tokyo 9
Amsterdam 8
Frankfurt am Main 8
Lauterbourg 8
Managua 8
Redondo Beach 8
Bari 7
Lappeenranta 7
London 7
Messina 7
Mexico City 7
Naples 7
Warsaw 7
Chennai 6
Florence 6
Helsinki 6
Houston 6
Quito 6
Tashkent 6
Brooklyn 5
Columbus 5
Dubai 5
Istanbul 5
Johannesburg 5
Paris 5
Reggio Calabria 5
Rio de Janeiro 5
Stockholm 5
Toronto 5
Baghdad 4
Birmingham 4
Borghetto Santo Spirito 4
Boston 4
Dammam 4
Manchester 4
Medellín 4
Medford 4
Mumbai 4
Princeton 4
San Francisco 4
Shanghai 4
Aracaju 3
Biên Hòa 3
Blumenau 3
Charlotte 3
Chicago 3
Clarkston 3
Cosenza 3
Guatemala City 3
Kuala Lumpur 3
Lawrenceville 3
Padua 3
Querétaro 3
Seattle 3
The Bronx 3
Turin 3
Vitória da Conquista 3
Abidjan 2
Amman 2
Ankara 2
Bagheria 2
Bishkek 2
Brasília 2
Brno 2
Brussels 2
Buenos Aires 2
Totale 1.765
Salva come PNG Salva come JPEG
Nome #
Real-life efficacy and satisfaction of long-acting ART CabotegravirRilpivirine in HIV-infected individuals 196
Efficacy of COVID-19 Vaccination in People Living with HIV: A Public Health Fundamental Tool for the Protection of Patients and the Correct Management of Infection 196
Methicillin‑sensitive Staphylococcus aureus prosthetic vascular graft infection after a Fontan procedure in an adult patient: A case report 166
Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV 165
HIV and Mediterranean Zoonoses: A Review of the Literature 163
COVID-19 and pregnancy: clinical outcomes and scientific evidence about vaccination 155
Pulmonary Kaposi Sarcoma without Respiratory Symptoms and Skin Lesions in an HIV-Naïve Patient: A Case Report and Literature Review 155
1605. Dual Therapy VS Triple Therapy in Experienced PLWH: a Multicentre One-Year Long Observational Study 152
1986. Switching to DOR/3TC/TDF Improves Renal Function and Decreases Lipid Levels in People Living With HIV: a Real-Life Multicentric Study 140
Arteriovenous fistula thrombosis in hemodialysis patients with COVID-19: epiphenomenon or marker of severe clinical disease? 140
Detection of SARS-CoV-2 in Ascitic Fluid of Cirrhotic COVID-19 Patients: Case Series and Literature Review 134
Diagnosis, Treatment, and Prevention of HIV Infection among Detainees: A Review of the Literature 133
Delirium during COVID‑19: A report of eight cases and a review of the literature 124
Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV 123
Analysis of the 2‑year real‑world efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV 111
CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation 108
All-cause and cause-specific mortality in people with HIV in Italy in 1997-2022: data from the Icona cohort 104
COVID‑19 infection and severe autoimmune haemolytic anaemia: A case report and review of the literature 104
Cryptococcosis in Pediatric Renal Transplant Recipients: Comparative Insights from Adult Cases 96
Bictegravir/Emtricitabine/ Tenofovir Alafenamide use significantly improves CD4/CD8 ratio in women living with HIV over a 48-week treatment, with good safety and effectiveness 90
Efficacy and Safety of Cabotegravir–Rilpivirine in PLWH: A Real-World Study 75
Restoring Control: Real-World Success with Imipenem–Relebactam in Critical MDR Infections—A Multicenter Observational Study 72
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 55
Real‑world effectiveness and safety of cefiderocol in critically ill patients with MDR Gram‑negative infections: Results from a retrospective study 53
Burden of advanced HIV disease among antiretroviral therapy-experienced persons with HIV in Italy over the past 20 years 48
The Challenging Scenario of Cancer Treatment for People with HIV: Clinical Experience with Immune Checkpoint Inhibitors 44
Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort 44
HIV INFECTION AMONG ADOLESCENTS AND YOUNG ADULTS IN ITALY: EPIDEMIOLOGY, VIRO-IMMUNOLOGICAL AND TREATMENT OUTCOMES 38
Role of low-frequency INSTI resistance mutations on virological outcomes in ART-Naïve individuals initiating second-generation integrase inhibitors 32
Did the COVID-19 pandemic shift the landscape of late HIV diagnosis? 29
Lipids and Body Mass Index in Antiretroviral‐Experienced People With HIV on Doravirine‐Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir‐Based Triple Regimen 28
Long-term trajectories of Hepatic and Metabolic biomarkers after switching from TDF to TAF in ART-Experienced PWH with and without Hepatic Coinfection: Data from the ICONA Cohort 21
Virological outcomes of PWH who discontinued cabotegravir/rilpivirine long-acting therapy in a real-world context 16
Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort 16
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study 15
Predictors of mortality and therapeutic efficacy in carbapenem-resistant Acinetobacter baumannii bacteremia 15
A machine learning-derived cardiovascular risk score in people with HIV: the ML-ICONA score 14
Implementation of HIV pre-exposure prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE cohort survey 9
Pre-ART platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio and the risk of non-AIDS-events, AIDS-events and mortality in people with HIV 9
Late or missed HIV diagnosis during pregnancy is still occurring in a high-income country and represents a high risk of MTCT 8
Implementing the National Vaccination Plan in people with HIV in Italy: A survey among ICONA centres 8
Distance from low-density lipoprotein cholesterol targets across cardiovascular risk strata in people living with HIV: a multicentre cohort study 7
Virologic, Lipid, Renal and Hepatic Laboratory Outcomes After Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Treatment-Experienced People with HIV: Real-World Evidence from the SHINe-SHIC Cohort 7
Obesity at antiretroviral therapy initiation and long-term risk of cardiovascular disease, cancer, or death in people with HIV in Italy: a prospective cohort study 6
Analytical description of adverse events with long-acting injectable cabotegravir and rilpivirine in people living with HIV: a large multicentre prospective observational cohort study (SCOLTA) 4
Tolerability and Virologic Outcomes after Transition from Long-Acting Injectable ART to Oral ART 4
Persistent ALT Elevation and Liver Outcomes After DAA-Induced HCV Cure in People With HIV: Impact of HBV and HDV Co-Infections 2
Higher risk of loss to follow-up among transgender people with HIV in Italy: findings from the ICONA cohort 2
Trends in Hepatitis D Virus Prevalence Among HBsAg‐Positive Individuals With and Without HIV in Italy: A Converging Epidemiology 2
Totale 3.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202239 0 0 0 0 0 0 6 5 4 6 7 11
2022/2023188 7 16 7 32 26 12 3 9 62 3 7 4
2023/202486 3 9 3 2 1 35 2 1 0 6 1 23
2024/2025520 13 21 8 25 46 16 25 99 87 33 76 71
2025/20262.205 125 137 143 192 177 384 233 245 247 213 61 48
2026/2027400 37 85 105 173 0 0 0 0 0 0 0 0
Totale 3.438